Paclitaxel, carboplatin, and extended-schedule etoposide in the treatment of small-cell lung cancer: comparison of sequential phase II trials using different dose-intensities. The chronologic changes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results